-
First Immunotherapy Approved for Breast CancerMedical oncologist Leisha A. Emens discusses the significance of the first U.S. Food and Drug Administration approval of an immunotherapy treatment for breast cancer.
by Anna Azvolinsky
-
Treating Cancer Based on Its Genetics, Not Its LocationMedical oncologist and sarcoma specialist George D. Demetri explains the significance of the recent approval of the oral drug Vitrakvi based on tumor genetics.
by Anna Azvolinsky
-
An Uncommon PartnershipThrough the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.
by Ashley P. Taylor
-
The Genetics of Metastatic CancerThe multiple tumors in patients with metastatic disease share key genetic traits, a sequencing study shows.
by Anna Azvolinsky
-
Paying for Tumor TestingA recent U.S. government decision about coverage of tumor sequencing could affect cancer patients.
by Brad Jones
-
The Ins and Outs of Tumor TestingIn a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates.
by Kate Yandell
-
A New Type of Drug ApprovalAt the AACR Annual Meeting, researchers and regulators discuss what it means to tie approval of an immunotherapy to tumors' molecular characteristics, not to their tissues of origin.
by Kate Yandell
-
A Better Way to Screen for Lynch Syndrome?Researchers say a next-generation sequencing test could improve screening in colorectal cancer patients for a hereditary syndrome that raises cancer risk. Some experts have concerns.
by Cheryl Platzman Weinstock
Participating in a structured exercise program after treatment was associated with a reduced risk of recurrence in people who had colon cancer.
by Sandra Gordon
Gaps in Survivorship Care Leave Unmet Needs After Cancer TreatmentA survey of head and neck cancer survivors reveals that many are not getting adequate survivorship care and may not even know it is available.
by Cameron Walker
Improving Communication for Deaf Cancer PatientsAfter a cancer diagnosis, people who are deaf or have hearing problems can struggle if accommodations don’t meet their communication needs.
by Eric Fitzsimmons
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose
-
From Discovery to SurvivorshipThe upcoming AACR Patient Advocate Forum will explore how advanced technologies are transforming cancer care, with a focused lens on immunotherapy, precision oncology, imaging, and survivorship.
-
What Are the Benefits of Exercise for Cancer Patients?Several recent studies have explored how exercise can impact a cancer patient’s survival, risk of recurrence, and overall quality of life.
Cancer Research at a Crossroads
